General Information of the Compound
| Compound ID |
CP0405092
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
8-[[2-[[(19S)-10,19-diethyl-7-hydroxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaen-19-yl]oxy]-2-oxoethyl]amino]-8-oxooctanoic acid
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C32H35N3O9
|
||||||||||||||||||
| Molecular Weight |
605.644
|
||||||||||||||||||
| Canonical SMILES |
CCc1c2Cn3c(cc4c(COC(=O)[C@@]4(CC)OC(=O)CNC(=O)CCCCCCC(O)=O)c3=O)-c2nc2ccc(O)cc12
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C32H35N3O9/c1-3-19-20-13-18(36)11-12-24(20)34-29-21(19)16-35-25(29)14-23-22(30(35)41)17-43-31(42)32(23,4-2)44-28(40)15-33-26(37)9-7-5-6-8-10-27(38)39/h11-14,36H,3-10,15-17H2,1-2H3,(H,33,37)(H,38,39)/t32-/m0/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
PXVNZGGLKJLEOS-YTTGMZPUSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00991, Histone deacetylase 1
Protein ID: PT00995, Histone deacetylase 3
Protein ID: PT01213, Histone deacetylase 6